Technical Analysis for NVUS - Novus Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.76 -2.54% -0.02
NVUS closed down 2.54 percent on Friday, September 13, 2019, on 54 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical NVUS trend table...

Date Alert Name Type % Chg
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Reached Overbought Strength -2.54%
Weak + Overbought Other -2.54%
Overbought Stochastic Strength -2.54%
50 DMA Resistance Bearish -2.07%
1,2,3 Retracement Bearish Bearish Swing Setup -2.07%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.07%
Shooting Star Candlestick Bearish 2.07%
Lizard Bearish Bearish Day Trade Setup 2.07%

Older signals for NVUS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.
Medicine Pharmaceutical Otorhinolaryngology Audiology Ear Pediatrics
Is NVUS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 5 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.21
52 Week Low 0.5717
Average Volume 77,920
200-Day Moving Average 2.425
50-Day Moving Average 0.8077
20-Day Moving Average 0.7398
10-Day Moving Average 0.7337
Average True Range 0.0673
ADX 29.39
+DI 16.2786
-DI 19.4152
Chandelier Exit (Long, 3 ATRs ) 0.6381
Chandelier Exit (Short, 3 ATRs ) 0.7736
Upper Bollinger Band 0.8137
Lower Bollinger Band 0.6659
Percent B (%b) 0.64
BandWidth 19.978373
MACD Line -0.0235
MACD Signal Line -0.0385
MACD Histogram 0.015
Fundamentals Value
Market Cap 5.28 Million
Num Shares 6.94 Million
EPS -3.46
Price-to-Earnings (P/E) Ratio -0.22
Price-to-Sales 0.00
Price-to-Book 1.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.82
Resistance 3 (R3) 0.83 0.81 0.81
Resistance 2 (R2) 0.81 0.80 0.81 0.81
Resistance 1 (R1) 0.79 0.79 0.78 0.78 0.80
Pivot Point 0.77 0.77 0.77 0.77 0.77
Support 1 (S1) 0.75 0.76 0.74 0.74 0.72
Support 2 (S2) 0.73 0.75 0.73 0.71
Support 3 (S3) 0.71 0.73 0.71
Support 4 (S4) 0.70